+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Intravenous immunoglobulin in Kawasaki syndrome: a progress report



Intravenous immunoglobulin in Kawasaki syndrome: a progress report



Pediatric Infectious Disease 5(3 Suppl.): S211-S215




(PDF emailed within 1 workday: $29.90)

Accession: 040496195

Download citation: RISBibTeXText

PMID: 3487077


Related references

A four-time-recurring typical complete Kawasaki syndrome successfully treated with intravenous immunoglobulin: a case report with literature review. Rheumatology International 33(10): 2653-2655, 2014

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?. Korean Circulation Journal 47(2): 179-181, 2017

Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. Journal of Pediatrics 163(2): 521-526, 2013

The effect of intravenous immunoglobulin on lymphocyte populations in children with Kawasaki syndrome. Clinical and Experimental Rheumatology 10(6): 617-620, 1992

Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome. Pediatric Dermatology 30(3): E30-E31, 2014

IL-1, IL-6 and TNFa activity in children with Kawasaki syndrome before and after treating with intravenous immunoglobulin. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 434, 1995

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. Bmc Pediatrics 18(1): 200, 2018

Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome. Pediatric Infectious Disease Journal 17(11): 1054-1056, 1998

The effect of intravenous immunoglobulin on lymphocyte populations and activation markers in kawasaki syndrome. Arthritis & Rheumatism 34(9 SUPPL): S121, 1991

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome. International Journal of Molecular Sciences 17(3): 278, 2016

Increasing Rate Of Intravenous Immunoglobulin Nonresponders Among Children With Acute Kawasaki Syndrome In San Diego County. Journal of Investigative Medicine 55(1): S122-S123, 2007

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases. Pediatric Rheumatology Online Journal 10(1): 10, 2012

Crystalline-like keratopathy after intravenous immunoglobulin therapy with incomplete kawasaki disease: case report and literature review. Case Reports in Ophthalmological Medicine 2013: 621952, 2013

A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review. Korean Journal of Pediatrics 59(Suppl 1): S60-S63, 2016

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report. Pediatric Rheumatology Online Journal 7: 3, 2009